Thomas G. Wiggans - 05 Dec 2022 Form 4 Insider Report for PARDES BIOSCIENCES, INC.

Role
Chief Executive Officer, Director
Signature
/s/ Elizabeth Lacy, attorney-in-fact
Issuer symbol
N/A
Transactions as of
05 Dec 2022
Net transactions value
+$13,625
Form type
4
Filing time
07 Dec 2022, 15:29:11 UTC
Previous filing
05 Dec 2022
Next filing
27 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PRDS Common Stock Purchase $13,625 +12,500 +33% $1.09 50,000 05 Dec 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price in Column 4 is a weighted average price. The prices actually paid ranged from $1.02 to $1.20. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price within the range.